Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Colesevelam in Pediatric Patients With Genetic High Cholesterol

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female patients~* Ages 10 to 17 years inclusive~* Diagnosis of heterozygous familial hypercholesterolemia~* On a stable dose of statin monotherapy or are treatment naive to lipid- lowering agents~* On a low-cholesterol diet~Exclusion Criteria:~* Patients should not have serious concomitant conditions that could interfere with the analysis of the results or that could interfere with the well-being of the patients

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- high dose colesevelam (Type: EXPERIMENTAL): colesevelam HCl 3.750 g
- Low dose colesevelam (Type: EXPERIMENTAL): Low dose colesevelam 1.875 g
- placebo (Type: PLACEBO_COMPARATOR): placebo comparator

Based on this trial design, predict the completion outcome and termination type (if applicable).